Maine AG Aaron Frey announced a settlement with Sanofi-Aventis U.S. LLC to resolve allegations that the pharmaceutical company’s deceptive pricing policies resulted in underinsured and uninsured patients having to pay higher list prices for insulin. According to the AG’s office, Sanofi will cap out-of-pocket insulin costs at $35 per month for Maine consumers through 2029. …

Read More

A bipartisan coalition of 50 AGs settled with Walgreens Boots Alliance, Inc. and Walgreen Co. (collectively, “Walgreens”) to resolve allegations that they billed federal and state government health care programs for prescriptions that were never picked up, in violation of the federal False Claims Act. According to the settlement agreement, Walgreens allegedly billed Medicare, Medicaid, and…

Read More

Oregon AG Dan Rayfield settled with AbbVie Inc. and Besins Healthcare, Inc. to resolve allegations that the pharmaceutical companies engaged in anti-competitive conduct relating to the sale of testosterone replacement gel in violation of state antitrust laws. The complaint alleged that AbbVie and Besins, among other entities, filed sham patent infringement litigation against a potential…

Read More

The National Association of Attorneys General (NAAG) sent a letter on behalf of a bipartisan coalition of 38 state and territory AGs requesting that the FDA act to protect consumers from counterfeit forms of weight loss and diabetes drugs (GLP-1 drugs). In the letter, the AGs explain that counterfeit GLP-1 drugs have entered the U.S. supply chain from foreign…

Read More

New York AG Letitia James, along with a bipartisan coalition of 15 other state AGs and additional parties, has reached a settlement in principle with members of the Sackler family and Purdue Pharma, Inc., to resolve allegations related to the company’s role in fueling the opioid crisis.

Read More